Rheumatoid Lung Disease:"All truth passes straight through three stages.
First, it is ridiculed.
Second, it is violently opposed.
Rheumatoid Lung Disease:The Cholesterol Conspiracy - The Truth About Statins And Nutritional Supplementation
Third, it is acceptable as being self-evident."
Arthur Schopenhauer
(1788 - 1860)
What is the true cause of heart disease, and how can we truly sell out the risk of death?
Atherosclerosis, or Coronary Artery Disease (Cad), is the foremost cause of death in both men and women. In the U.S. Alone, there are more than one million heart attacks every year, one third of them resulting in death. The majority of men and women currently have, or are actively developing, atherosclerosis. By age 20, most habitancy already have a 15-25% narrowing of their arteries due to plaque formation. By age 40, there is a 30-50% clogging of their arteries.
In the beginning of the Twentieth Century, congestive heart disease (Chd) was mostly a succeed of rheumatic fever, which was a childhood disease. However by the year 1936 there was a dramatic change in the main cause of heart disease. Cardiovascular disease caused by atherosclerosis, or plaque buildup, took first place as the former cause of heart disease, making congestive heart failure a distant second.
During the 1950's, the autopsies conducted on men who died of heart disease that revealed plaque-clogged arteries fulfilled, that cholesterol was the cause of hardening of the arteries (atherosclerosis) and coronary artery disease. Cholesterol, not calcium, was thought about the "cause" of heart disease, despite plaque consisting of 95% calcium and a relatively small division of cholesterol. By 1956 there were 600,000 deaths annually from heart disease in the U.S. Of those 600,000, 90% were caused by atherosclerosis, or clogged arteries. In fewer than 25 years, the amount one cause of death in the U.S. Had changed dramatically ...from congestive heart disease to coronary artery disease.
Because cholesterol was dubbed the "cause" of atherosclerosis, the exertion to lower cholesterol by any means began in earnest. Both the food manufactures and the pharmaceutical manufactures seized upon this occasion to cash in on a cholesterol-lowering campaign by creating foods and drugs that would supposedly save lives. Diets, such as the economical Diet, were established to lower the amount of cholesterol intake from food. There was no doubt that both polyunsaturated oils and drugs reduced cholesterol, but by 1966 it was also apparent that lowering cholesterol did not translate into a reduced risk of death from heart disease.
As there was so much money to be made from pharmaceutical development, the campaign to furnish cholesterol-lowering drugs kicked into high gear, despite the lack of evidence showing that the lowering cholesterol reduced the risk of untimely death from heart disease.
Heart disease kills 725,000 Americans annually, with women accounting for 2/3 or nearly 500,000 of those deaths. After thirty years of cholesterol-lowering medications' failure to significantly lower the death rate from cardiovascular disease, in 1987 a new and more hazardous class of drugs was unleashed upon the world: the "statin" drugs. Cholesterol-lowering statin drugs are now the acceptable of care that physicians are indoctrinated into prescribing to sell out cardiovascular disease. Are statin drugs the best way to preclude heart attacks and death?
Before 1936 the most tasteless type of heart disease was congestive heart disease (Chd). It rarely caused sudden death and could be treated with the drug digitalis. The incidence of Chd remained stable until 1987, after which the incidence of the disease skyrocketed. Interestingly, the timing of the increased incidence of congestive heart disease coincides with the introduction of cholesterol-lowering statin drugs. Could cholesterol-lowering statin drugs have something to do with the weakening of heart muscles and the increased incidence of congestive heart failure? We will see that lowering the body's co-enzyme Q10 levels, a side succeed of statin drugs, does honestly growth the risk of muscle damage, along with the muscles of the heart.
Atherosclerosis is a disease characterized primarily by inflammation of the arterial lining caused by oxidative damage from homocysteine, a toxic amino acid intermediary found in everyone. Homocsyteine, in composition with other free radicals and toxins, oxidizes arteries, Ldl cholesterol, and triglycerides, which in turn releases C Reactive Protein (Crp) from the liver-a label of an inflammatory response within the arteries. Inflammation (oxidation) is the beginning of plaque buildup and ultimately, cardiovascular disease. Plaque, combined with the thickening of arterial smooth muscles, arterial spasms, and clotting, puts a someone at a high risk of suffering heart strike or stroke.
For years, doctors have hyper-focused on cholesterol levels. First it was the total cholesterol; later the focus became the ratio of "good" Hdl cholesterol to "bad" Ldl cholesterol. In other words, how much of your cholesterol was good, and how much was bad? Of the two, the foremost parameter is the level of Hdl cholesterol, not Ldl cholesterol. Hdl, or high-density lipoprotein cholesterol, is responsible for clearing out the Ldl cholesterol that sticks to arterial walls. Exercise, vitamins, minerals, and other antioxidants, particularly the bioflavonoid and olive polyphenol antioxidants, growth Hdl cholesterol levels and protect the Ldl cholesterol from oxidative damage, and therefore do more to sell out the risk of heart disease than any medication ever could.
There is nothing inherently bad about Ldl cholesterol. Ldl cholesterol is necessary to utter life. Ldl cholesterol only becomes "bad" when it is damaged, or oxidized by free radicals. Only the damaged, or oxidized form of Ldl cholesterol sticks to the arterial walls to kick off the formation of plaque.
Let us look towards cigarette smoking for a easy example demonstrating that we honestly need to sell out oxidized Ldl cholesterol to preclude atherosclerosis, as opposed to indiscriminately lowering Ldl cholesterol with statin drugs. Every person knows that cigarette smoking increases the risk of many persisting diseases, such as cancer, heart disease, and stroke. Smokers with general levels of Ldl cholesterol are at an even greater risk of developing heart disease than a non-smoker who has elevated levels of Ldl cholesterol. Of procedure the presume why a smoker with general levels of Ldl cholesterol is at greater risk of disease is because his Ldl gets excessively oxidized.
Cigarette smoke releases so many toxins and free radicals that the Ldl cholesterol, the triglycerides, and the arterial walls are extensively oxidized. Homocysteine levels are also increased by cigarette smoking which further oxidizes Ldl cholesterol and the arterial lining. Oxidation is the initiating cause of atherosclerosis. Therefore, the more and longer one smokes, the more oxidative damage he sustains and the greater his risk of developing heart disease. The degree of oxidation directly corresponds to the risk of heart disease.
If you are not taking vitamins, minerals, and antioxidants then your Ldl cholesterol is being oxidized, it is sticking to your arterial walls, and you Are developing heart disease Even If Your Cholesterol Levels Are Normal! Ldl cholesterol starts sticking to arterial walls before the age of 5.
Among the many free radicals that damage cholesterol, triglycerides and the arterial lining is homocysteine, a toxic intermediate biochemical produced while the conversion of the amino acid methionine into an additional one foremost amino acid, cysteine. Both methionine and cysteine are non-toxic, but homocysteine is very toxic to the lining of the arterial endothelium. Homocysteine oxidizes Ldl cholesterol, triglycerides and the arterial lining.
Homocysteine is an amino acid usually produced in small amounts from the amino acid methionine. The general role of homocysteine in the body is to control growth and support bone and tissue formation. However a problem arises when homocysteine levels in the body are elevated, causing inordinate damage to Ldl cholesterol, as well as to arteries. Furthermore, homocysteine honestly stimulates growth of arteriosclerotic plaque, which leads to heart disease.
Thyroid hormone controls the level of homocysteine, but numerous factors play a role in the elevation of homocysteine. general aging, kidney failure, smoking, some medications, and commercial toxins all elevate homocysteine levels. Interestingly, estrogen helps lower homocysteine.
Homocysteine becomes elevated in the blood with a insufficiency of the B vitamins-B6, B12 and folic acid. Genetics also play a role. About 12% of the habitancy has an undetected defect requiring higher levels of folic acid than the rest of habitancy to help utter homocysteine levels in a safe range (below 6.5). Therefore if you have high homocysteine levels (> 7.0) even though you are taking supplemental B complicated vitamins, then you may be among the 12% who need more than 1000 mcg of folic acid per day. In addition, betaine, also known as trimethylglycine (Tmg) lowers homocysteine.
Homocysteine is second only to cigarette smoking in its oxidative destruction. It causes small nicks or tears in the arterial lining, while also oxidizing and damaging Ldl cholesterol. The damaged, or oxidized Ldl cholesterol sticks to the homocysteine-damaged areas of the arterial lining. The composition of oxidized Ldl cholesterol and a damaged arterial lining is what causes Ldl cholesterol to stick to the arteries, either or not the Ldl cholesterol level is normal.
Cholesterol-lowering statin drugs are the acceptable for treating high cholesterol. This is dogma, and whatever who states otherwise is committing medical heresy. Many habitancy find it hard to believe that pharmaceutical fellowships could ever succeed in paying medical researchers, medical associations, and doctors to suggest something detrimental to our health.
Most habitancy do not know that pharmaceutical fellowships fund medical institutions, medical education, medical conferences, and still recompense doctors and investigate institutions for providing favorable results on their drugs. Likewise, pharmaceutical fellowships often suppress negative results from studies done on their drugs. Money has the power to sweep negative results and serious side effects under the rug. Money has the power to work on the Fda to decide which drugs make it to shop and which drugs become the "standard" of treatment.
Former editor of the New England Journal of medicine (Nejm), Dr. Marcia Angell, warned of the problem of commercializing scientific investigate in her outgoing editorial titled "Is academic medicine for Sale?" Angell called for stronger restrictions on pharmaceutical stock proprietary and other financial incentives for researchers. She said that growing conflicts of interest were tainting science, warning "When the boundaries between manufactures and academic medicine become as blurred as they are now, the business goals of manufactures work on the mission of medical schools in multiple ways." She did not reduction the benefits of investigate but said, "a Faustian bargain" now existed between medical schools and the pharmaceutical industry. Angell left the Nejm in June 2000 and has written a book, "The Truth About the Drug Companies: How They Deceive Us and What to Do About It."
Two years later, in June 2002, the Nejm announced that it was going to begin accepting articles that were written by biased researchers, as there weren't adequate unbiased researchers left to write articles. In other words, most investigate institutions were now funded by one or more of the numerous pharmaceutical companies.
An Abc narrative noted that a observe of clinical trials revealed that when a drug business did not fund a study, favorable results concerning a drug were found only 50% of the time. In studies funded by drug fellowships favorable results about the drugs were reported an astonishing 90% of the time. Money can and does buy the desired results. This is how most medical investigate and drugs are now advanced and brought to market.
In 1977, the internationally-renowned heart surgeon, Dr. Michael DeBakey pointed out that only 30-40% of habitancy with blocked arteries and heart disease have elevated blood cholesterol levels, and posed the logical question, "How do you account for the other 60-70%?"
Because lowering cholesterol did not sell out the risk of death from heart disease, the Cholesterol Consensus argument in 1984 advanced new guidelines to lower the "acceptable level" of cholesterol. High cholesterol would now be the pathology for any man or woman with a cholesterol level over 200. Doctors had to convince their patients that they had the disease and needed to take one or more high-priced drugs for the rest of their lives.
However, when lowering total cholesterol levels below 200 did not translate into saving lives from heart attacks, the focus then turned to Ldl cholesterol levels. The "disease" of high cholesterol was refined to the disease of high Ldl cholesterol. The unfortunate sick person who had an Ldl cholesterol level above 130 was now condemned to a lifetime of high-priced drugs. Though fully illogical, even when a someone with general Ldl cholesterol levels suffered a heart attack, he would still be prescribed a cholesterol-lowering drug.
As we shall see, statin drugs sell out the risk of death by repeat heart attacks by as much as 30%, but interestingly enough, the mechanism of performance in reducing the risk of death after a heart strike is not via statin drugs' quality to lower cholesterol! It has been discovered that statin drugs have a modest anti-inflammatory and antioxidant effect. Yet, there are many natural antioxidants that sell out inflammation and oxidation of Ldl cholesterol and the lining of the arteries, which may soon be discovered to be more productive in reducing the risk of death than "antioxidant drugs," without toxic side effects.
The myth that high Ldl cholesterol is the former cause of heart disease, and that we must be on drugs to protect ourselves is dispelled by the evidence. If the premise were true that habitancy with high levels of Ldl cholesterol get heart disease, then we could assume that habitancy with general levels of Ldl should not get heart disease, or at least very few should get it. However, as Dr. DeBakey observed, almost 60% of those who die from heart disease have general Ldl cholesterol levels!
Furthermore, after over 45 years of doctors prescribing cholesterol-lowering drugs, heart disease and stroke still remain the amount one cause of death in both women and men. This says that regardless of either you have a high or a general level of cholesterol, you have a 50% occasion of dying from heart disease. If this is so, and it is, then why take a hazardous drug to exertion to lower your cholesterol in the first place?
In 2001, the target level of Ldl cholesterol was lowered from 130 to 100, and overnight the amount of habitancy thought about to be candidates for cholesterol statin drugs doubled. Many habitancy such as myself bristled at the news, because we knew the effectiveness of vitamins, minerals, and antioxidants in preventing and reversing heart disease. Many of us could see the conspiracy for what it was.
The level at which Ldl cholesterol is thought about general has continually been influenced by pharmaceutical companies, who pull the financial strings of investigate grants that keep medical schools and medical organizations in business. The lower they can manufacture the level at which Ldl cholesterol is thought about to be normal, the more habitancy automatically become victims of the dreaded disease of "high cholesterol." Therefore, more habitancy will be persuaded that they need to be taking a statin drug, and voilà, more profit for the manufacturers. When you consider the size of the profits already received, let alone the inherent profit from statin drugs over the next any years, the cholesterol conspiracy is one of the largest money making schemes ever perpetrated on the world.
In July 2004, the level of Ldl cholesterol thought about general underwent an additional one change. The new norm plunged from 100 to 70, virtually doubling again the amount of habitancy who are "infected" with the plague of high cholesterol. Why, it's the epidemic of our time! Many enlightened habitancy howled at this news, wondering if the masses would ever wake up and see who is behind this, and why. Why is the medical making ready ignoring the thousands of published medical studies that show the beneficial effects of nutritional supplements against heart disease? Why is the medical making ready down-playing the hazardous and deadly side effects of statin drugs?
The "updated" Ldl cholesterol recommendations were published in the July 2004 issue of the American Heart Association's publication, Circulation. A panel from the National Heart, Lung and Blood Institute, a branch of the National Institutes of Health, which is endorsed by the American College of Cardiology, and the American Heart Association, were the ones who honestly pronounced the new cholesterol level at which drugs should be prescribed. Sounds pretty official and dependable if these considerable medical institutions are backing up these recommendations, right?
The fact is eight of the nine panel members making the new Ldl cholesterol recommendations were being paid by the statin-producing pharmaceutical companies. The panelists did not disclose their financial friction of interest. This information was uncovered by Newsday, a Long Island, New York
newspaper (D. Ricks and R. Robins, Newsday, July 15, 2004). Seven of the nine panelists have financial connections to Pfizer, the makers of Lipitor®. Five of the nine served as "consultants" to Pfizer. So, what did the other two panelists do to deserve their money? Seven of the nine panelists also received money from Merck, the producers of Zocor®, with four of them serving as "consultants" to the company. Eight of the panelists who made the recommendations that would growth the prescribing of statin drugs have received either investigate grants or honoraria from Pfizer, Merck, AstraZeneca, Novartis, Glaxo Smith Kline, Johnson & Johnson, Bayer, and many other drug fellowships that furnish statin drugs.
You would think that with all the advertising and recommendations from medical experts on the benefits of statin drugs, the medical society would possess astonishing evidence that the drugs sell out the risk of death from cardiovascular disease. A hint of some of the smoke and mirrors in the pharmaceutical companies' advertising can be seen in their Tv commercials. Read thought about the small print on some of Crestor's® commercial advertising. Their commercial states how much it lowers Ldl cholesterol. However, in the same ad you can read, "...Crestor® has not been shown to sell out the risk of heart disease or heart attack." If so, then why take it? Isn't the lowest line to preclude death?
The principles for reporting adverse effects from medications is tremendously flawed, so much so that many habitancy are seriously harmed or killed by some medications before they are finally removed from the market. Most doctors do not know what symptoms or effects are due to the drug, what should be reported, or even to whom to narrative adverse effects. They assume that the investigate that went into developing the drug has already identified all the effects and that a drug brought to shop is "safe." However, only one in twenty side effects is ever reported to either hospital administrators or the Fda.
Statin drugs block cholesterol yield in the body by inhibiting the enzyme called Hmg-CoA reductase in the early steps of its synthesis in the mevalonate pathway. Cholesterol is one of three end products in the mevalonate chain. This same biosynthetic pathway is also used to originate co-enzyme Q10, or co-Q10, as well as dilochol. Therefore, one unfortunate consequence of statin drugs is the unintentional inhibition of both Co-Q10 and dilochol synthesis.
The drug information insert of a statin drug states that it lowers co-enzyme Q10 levels. Most doctors have forgotten their biochemistry class in medical school, and forgotten about the importance of Co-Q10. Therefore they apparently are not implicated about such a statement on the drug labeling information sheet. They may even reassure their patients that lowering Co-Q10 is nothing to worry about, but at the same time warn them that the drug may cause liver damage and to have their liver enzymes checked every three to six months to make sure the drug isn't killing them. They do not realize that it is the depletion of Co-Q10 that leads to liver damage and death.
Ubiquinone, or co-enzyme Q10, is a necessary cellular nutrient created in the cell's mitochondria, the "engines" that furnish vigor for the cell. Mitochondria use sugar, oxygen, and water to furnish vigor molecules known as Atp. Without Atp cells could do nothing. Damaged tissues could not be repaired. Cells could not divide or furnish or apply proteins, enzymes, or hormones. Death of cells, and honestly of the human body would occur if Atp could no longer be produced and utilized. Co-Q10 functions within the mitochondria as an electron carrier to cytochrome oxidase, our main respitory enzyme, which helps turn oxygen and sugar into energy. The heart requires high levels of oxygen, sugar, and Co-Q10 since it utilizes a lot of energy. A form of Co-Q10 called ubiquinone is found in all cell membranes, where it plays a role in maintaining membrane integrity, so necessary to nerve conduction and muscle contraction. Co-Q10 is also vital for the formation of elastin and collagen, which make up the connective tissues of the skin, musculature, and the cardiovascular system.
The most tasteless side succeed of statin drugs is muscle pain and weakness. In fact, many patients who start on the statin drugs almost immediately observation generalized fatigue and muscle weakness. This is due to the depletion of Co-Q10 needed to support muscle function. Dr. Beatrice Golomb of San Diego, California, is currently conducting a series of studies on statin side effects. The pharmaceutical manufactures insists that only 2-3% of patients get muscle aches and cramps, when in fact in one study, Golomb found that 98% of patients taking Lipitor®, and one-third of the patients taking Mevacor® (a lower dose statin), suffered noticeable to necessary muscle problems.
Some habitancy on statin drugs lose coordination of their muscles. Some manufacture pain in their muscles, some are not able to write due to loss of fine motor skills. Many lose the compel to exercise. Others are falling more often as their muscles give out, still others have issue sleeping due to muscle cramping and twitching. Even worse, many habitancy are experiencing most of these side effects. The problems are so numerous, it is difficult to list all the symptoms habitancy might experience. These problems do not come from the "disease" of high cholesterol, but the disease of ignorance in prescribing these drugs.
As we age, Co-Q10 levels decline naturally. From the age of 20 to 80, Co-Q10 levels fall by nearly 50%. Along with the natural decline of Co-Q10, comes a natural decrease in vigor and an growth in the risk of heart disease, stroke, and cancer. If the natural decline of Co-Q10 levels increases the risk of fatigue, cancer, heart disease, and stroke, would it not make sense that accelerating the decline of Co-Q10 levels with statin drugs would have the same effect? They do indeed!
Demonstrating the importance of Co-Q10 to cardiovascular health, in a randomized, duplicate blind, placebo-controlled study of habitancy either taking or not taking statin drugs, supplementation with Co-Q10 reduced the risk of heart attacks and death in those with heart disease and prior heart attacks by 50%, regardless of either they were on a statin drug or not. (Singh R, Neki N, Kartikey K, et al. succeed of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction. Mol Cell Biochem. 2003 Apr; 246(1-2):75-82.)
Additionally, Co-Q10 was shown to growth blood levels of vitamin E and significantly growth the levels of protective Hdl. As low Hdl is a major risk factor for heart disease, addition it is a exact benefit. Statin drugs were shown not to furnish any benefit beyond that of supplementing with Co-Q10. Let me make this clear - in this study only the co-enzyme Q10 in case,granted any benefit, not the drugs!
Cardiologist Dr. Peter Langsjoen of East Texas University reported the effects of Lipitor® among 20 patients who started with fully general hearts. After six months on a low dose of 20 mg of Lipitor® per day, two thirds of the patients started to show signs of heart failure, as seen by abnormalities in the heart's filling phase. According to Dr. Langsjoen, this malfunction is due to Co-Q10 depletion. Nine controlled trials using statin drugs in humans have been conducted thus far. Eight of these showed necessary statin-induced Co-Q10 depletion foremost to a decline in left ventricular function and other biochemical imbalances.
In the United States, the incidence of heart attacks over the past ten to fifteen years has declined slightly. But congestive heart failure and cardiomyopathy have risen alarmingly. Is it a coincidence that statin drugs were first marketed in 1987, and then from 1989 to 1997, deaths from congestive heart failure more than doubled? 38 It scares me that virtually all patients with heart failure are put on statin drugs, even if their cholesterol is already low. In my opinion, the worst thing to do for a failing heart is take a statin drug. The best thing is to take is a full range of quality nutritional supplements, ...vitamins, minerals, fish oil, and other antioxidants, along with Co-Q10.
Various antioxidants work synergistically, each contributing to the fight against free radicals in separate areas and in separate ways. In the blood stream, water-soluble antioxidants, such as vitamin C, and grape seed extract come in caress with and neutralize free radicals before they damage Ldl-cholesterol. Other antioxidants saturate arterial walls and other tissues, and protect collagen and elastic fibers from free radical damage, reducing inflammation and plaque formation. The fat-soluble antioxidants, vitamin E, beta carotene, and co-enzyme Q10 ride along in the blood fat (triglycerides) and Ldl cholesterol, protecting them and the endothelium from oxidation. Vitamin E sits on the face of Ldl cholesterol, protecting it from free radical damage. Beta carotene, grape seed extract and olive extract perforate deeper inside the Ldl cholesterol and arterial walls, adding more protection from oxidation. Quercetin and alpha lipoic acid work straight through nitrous oxide pathways to sell out high blood pressure, a major risk factor for heart disease.
A narrative published in the Archives of Internal medicine in 2005 looked at 97 double-blind controlled studies comparing the efficacy of cholesterol-lowering statin drugs to fish oil. They found that cholesterol-lowering statin drugs reduced the risk of death from heart disease by only 13%, and
interesting adequate it was Not due to the succeed of lowering cholesterol. The benefits, although small, were derived from the fact that statin drugs have a small antioxidant effect.
Even more interesting, the salmon oil was shown to sell out the risk of death from heart disease by 23%, nearly duplicate the benefit of statin drugs. Salmon oil is an omega-3 fatty acid that gets incorporated into cholesterol and triglycerides and prevents the oxidation of Ldl cholesterol. Since Ldl cholesterol is protected from inordinate oxidation there is less plaque buildup and less risk of heart disease.
Inflammation is a familiar component in the formation of atherosclerosis. To keep it simple, think of inflammation and oxidation as the same process. The immune system's response to inflammation is to
release peroxides that act like acid to break down damaged tissues, so that cells from the immune system, macrophages, can consume the molecules and clean up the site. But peroxides escalate the oxidation/inflammation process, thus damaging more tissue. The arterial walls become more inflamed, escalating the formation of plaque and scarring. The downward cycle continues until atherosclerosis is so advanced that the occurrence of a heart strike or stroke becomes imminent.
The liver's response to inflammation is to release C reactive protein (Crp) into the blood. Other inflammatory causes can cause elevated Crp levels, along with cigarette smoking, obesity, insulin insensitivity, diabetes, rheumatoid arthritis, infections, dementia, colorectal cancer, high blood pressure, and aging. Accordingly, elevated Crp levels are a direct indication of inflammation in the body and that atherosclerosis, along with heart disease, is actively developing.
Homocysteine and high sensitivity Crp levels can and should be tested. Dr. Jialal, of the Universtity of Texas Southwestern medical School at Dallas, is well known for his investigate correlating oxidized Ldl cholesterol as the true cause of atherosclerosis, has also identified high sensitivity C reactive protein as a predictive risk factor for inflammation of arterial walls and plaque formation. Your doctor may not test for these routinely, but you should insist on getting these tests done. Both of these predictive values can be kept at "safe" levels. Vitamins, minerals, antioxidants, and omega-3 fatty acids can lower the levels of homocysteine and Crp. The B vitamins, along with betaine, or tri-methyl-glycine (Tmg), change homocysteine into safer amino acids and sell out inflammation of the Ldl cholesterol and the arterial lining.
When you receive the results of your homocysteine test, do not accept the answer, "Your test was normal." Ask for the actual number. The doctor and nurse usually know what is general by what the lab slip states as the "normal range." Most lab results narrative a general homocysteine level as being below 10.4, when in fact, since the early 1990's, researchers have known that a homocysteine count above 6.5 signals a rapid linear rise in the risk for heart disease.
Furthermore, with every 3 point elevation of homocysteine above 6.5, e.g., when homocysteine levels are 9.5, the risk of coronary artery disease (Cad) rises by an further 35%! Yet you may be told that 9.5 is "normal and not to worry." With a homocysteine level of 12.5, the growth in the
risk for heart disease exceeds 70%. The greater the homocysteine level, the greater the oxidation
of both Ldl cholesterol and the arterial lining. The greater the inflammation, the higher the Crp. Is it any wonder that homocysteine and Crp levels are more predictive for risk of heart disease than cholesterol levels and ratios?
I need to emphasize that whatever either they have a medical problem or not, should discuss this information with their doctor before acting upon whatever written here. The information in case,granted is not meant to diagnose or treat any disease. It is for informational purposes only; and no one should make decisions about their medications without consulting with their physician. No one should come off a cholesterol-lowering statin drug in lieu of nutritional supplements without a acceptable argument with their doctor who is keenly aware of all the pros and cons of both medicine modalities.
In summary, I suggest a full spectrum of quality nutritional supplements, along with a healthy diet and exercise, to help fetch and utter optimal heart and arterial health. I believe all would agree that lifestyle changes are the most foremost factor for optimal health, ...and many believe that quality nutritional supplements are key in protecting against the process that leads to, and accelerates the amelioration of almost all persisting degenerative diseases, that of oxidation. To combat oxidation we need a full range of quality antioxidants.
http://comparativeguide.com
Rheumatoid Lung Disease:The Cholesterol Conspiracy - The Truth About Statins And Nutritional Supplementation
